Philip D. Dunne

12.9k total citations · 1 hit paper
71 papers, 6.1k citations indexed

About

Philip D. Dunne is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Philip D. Dunne has authored 71 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 28 papers in Molecular Biology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Philip D. Dunne's work include Colorectal Cancer Treatments and Studies (16 papers), Genetic factors in colorectal cancer (16 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Philip D. Dunne is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Genetic factors in colorectal cancer (16 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Philip D. Dunne collaborates with scholars based in United Kingdom, United States and Ireland. Philip D. Dunne's co-authors include Manuel Salto‐Tellez, Darragh G. McArt, Maurice B. Loughrey, Peter W. Hamilton, Helen G. Coleman, Stephen McQuaid, Peter Bankhead, Jacqueline A. James, Ronan T. Gray and Liam Murray and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Philip D. Dunne

68 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

QuPath: Open source software for digital pathology image analysis

2017 4.6k citations Peter Bankhead, Maurice B. Loughrey et al. profile →

Peers

Countries citing papers authored by Philip D. Dunne

Since Specialization

Citations

This map shows the geographic impact of Philip D. Dunne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Dunne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Dunne more than expected).

Fields of papers citing papers by Philip D. Dunne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Dunne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Dunne. The network helps show where Philip D. Dunne may publish in the future.

Co-authorship network of co-authors of Philip D. Dunne

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Dunne. A scholar is included among the top collaborators of Philip D. Dunne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Dunne. Philip D. Dunne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy 2024 ·npj Precision Oncology ·Maxime W. Lafarge, Enric Domingo, Korsuk Sirinukunwattana, (unknown), Leslie Samuel, Graeme I. Murray, Susan D. Richman, Andrew Blake, David Sebag‐Montefiore, Simon Gollins, E. Klieser, Daniel Neureiter, Florian Huemer, Richard Greil, Philip D. Dunne, Philip Quirke, Lukas Weiß, Jens Rittscher, Tim Maughan, Viktor H. Koelzer	9
2	Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data 2022 ·Disease Models & Mechanisms ·(unknown), Raheleh Amirkhah, James G. Jackson, Tamsin R.M. Lannagan, Kathryn Gilroy, Sudhir B. Malla, Keara L. Redmond, (unknown), Simon S. McDade, Tim Maughan, Simon J. Leedham, Andrew D. Campbell, Owen J. Sansom, Mark Lawler, Philip D. Dunne	3
3	Tumour invasion and dissemination 2022 ·Biochemical Society Transactions ·(unknown), Philip D. Dunne, Vijay Tiwari	18
4	Development of a semi‐automated method for tumour budding assessment in colorectal cancer and comparison with manual methods 2021 ·Histopathology ·Natalie C. Fisher, Maurice B. Loughrey, Helen G. Coleman, (unknown), Peter Bankhead, Philip D. Dunne	13
5	Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer 2021 ·Molecular Cancer Therapeutics ·Nyree Crawford, (unknown), Tamas Sessler, Christopher McCann, (unknown), (unknown), (unknown), (unknown), Joanne M. Munck, Tomoko Smyth, (unknown), Vanessa Martins, Mark Lawler, Philip D. Dunne, Emma Kerr, Simon S. McDade, Vicky M. Coyle, Daniel B. Longley	21
6	Downregulation of PPARα during Experimental Left Ventricular Hypertrophy is Critically Dependent on Nox2 NADPH Oxidase Signalling 2020 ·International Journal of Molecular Sciences ·Adam Harvey, Emma Robinson, Kevin Edgar, (unknown), (unknown), (unknown), Raheleh Amirkhah, Philip D. Dunne, Barbara J. McDermott, David Grieve	12
7	ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA 2019 ·Cancer Research ·(unknown), (unknown), Kienan I. Savage, Paul G. O’Reilly, (unknown), Philip D. Dunne, Mark Lawler, Simon S. McDade, David Waugh, Darragh G. McArt	6
8	The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer 2019 ·Cells ·Raheleh Amirkhah, Hojjat Naderi‐Meshkin, Jaynish S. Shah, Philip D. Dunne, Ulf Schmitz	34
9	ATU-06 Does the timing of TIPSS in patients with acute oesophageal variceal bleeding alter patient outcome? 2019 ·Philip D. Dunne, Rohit Sinha, Dhiraj Tripathi, Peter Hayes	3
10	Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer 2018 ·Cancer Immunology Research ·Grace O’Malley, Oliver Treacy, Kevin Lynch, (unknown), Niamh Leonard, Paul Lohan, Philip D. Dunne, Thomas Ritter, Laurence J. Egan, Aideen E. Ryan	68
11	Epithelial‐to‐mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition 2018 ·The Journal of Pathology ·Amy M.B. McCorry, Maurice B. Loughrey, Daniel B. Longley, Mark Lawler, Philip D. Dunne	18
12	Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis 2018 ·Histopathology ·Maurice B. Loughrey, Peter Bankhead, Helen G. Coleman, (unknown), Stephanie G. Craig, Amy M.B. McCorry, Ronan T. Gray, Stephen McQuaid, Philip D. Dunne, Peter W. Hamilton, Jacqueline A. James, Manuel Salto‐Tellez	59
13	Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies 2018 ·The Journal of Pathology ·(unknown), Susan D. Richman, Simon Gollins, Peter Stewart, Chris Hurt, Richard Adams, Amy M.B. McCorry, (unknown), Dale Vimalachandran, Claudio Isella, Enzo Médico, Tim Maughan, Darragh G. McArt, Mark Lawler, Philip D. Dunne	40
14	Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification 2017 ·Nature Communications ·Philip D. Dunne, (unknown), Paul G. O’Reilly, (unknown), Amy M.B. McCorry, Susan D. Richman, Tim Maughan, Simon S. McDade, Patrick G. Johnston, Daniel B. Longley, Elaine W. Kay, Darragh G. McArt, Mark Lawler	53
15	IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer 2017 ·Cell Death Discovery ·Ryan Hutchinson, Helen G. Coleman, Kathy Gately, Vincent Young, Siobhan Nicholson, Robert Cummins, Elaine W. Kay, Seán O. Hynes, Philip D. Dunne, (unknown), Peter W. Hamilton, Darragh G. McArt, Daniel B. Longley	5
16	Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy 2016 ·Cancer Immunology Research ·Philip D. Dunne, Darragh G. McArt, Paul G. O’Reilly, Helen G. Coleman, Wendy L. Allen, Maurice B. Loughrey, Sandra Van Schaeybroeck, Simon S. McDade, Manuel Salto‐Tellez, Daniel B. Longley, Mark Lawler, Patrick G. Johnston	31
17	Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer 2016 ·Clinical Cancer Research ·Philip D. Dunne, Darragh G. McArt, Conor A. Bradley, Paul G. O’Reilly, Helen L. Barrett, Robert Cummins, (unknown), Ken Arthur, Maurice B. Loughrey, Wendy L. Allen, Simon S. McDade, David Waugh, Peter W. Hamilton, Daniel B. Longley, Elaine W. Kay, Patrick G. Johnston, Mark Lawler, Manuel Salto‐Tellez, Sandra Van Schaeybroeck	103
18	EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer 2015 ·Clinical Cancer Research ·Philip D. Dunne, Sonali Dasgupta, Jaine K. Blayney, Darragh G. McArt, Keara L. Redmond, (unknown), Conor A. Bradley, Takehiko Sasazuki, Senji Shirasawa, Tingting Wang, Supriya Srivastava, Chee Wee Ong, Ken Arthur, Manuel Salto‐Tellez, Richard H. Wilson, Patrick G. Johnston, Sandra Van Schaeybroeck	108
19	AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer 2013 ·Clinical Cancer Research ·Philip D. Dunne, Darragh G. McArt, Jaine K. Blayney, Murugan Kalimutho, (unknown), Tingting Wang, Supriya Srivastava, Chee Wee Ong, Ken Arthur, Maurice B. Loughrey, Keara L. Redmond, Daniel B. Longley, Manuel Salto‐Tellez, Patrick G. Johnston, Sandra Van Schaeybroeck	89
20	Pharmacogenomic Profiling and Pathway Analyses Identify MAPK-Dependent Migration as an Acute Response to SN38 in p53 Null and p53-Mutant Colorectal Cancer Cells 2012 ·Molecular Cancer Therapeutics ·Wendy L. Allen, Richard Turkington, Leanne Stevenson, (unknown), Vicky M. Coyle, Suzanne Hector, Philip D. Dunne, Sandra Van Schaeybroeck, Daniel B. Longley, Patrick G. Johnston	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact